Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study

Many drugs have been tried for the treatment/prevention of COVID-19 with limited success. Direct household contacts of COVID-19 patients are at highest risk for SARS-CoV-2 infection. Hydroxychloroquine (HCQ) has been tried against COVID-19 owing to its in vitro virucidal action against SARS-CoV-2, b...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Antimicrob Agents
Main Authors: Dhibar, Deba Prasad, Arora, Navneet, Kakkar, Arpit, Singla, Neeraj, Mohindra, Ritin, Suri, Vikas, Bhalla, Ashish, Sharma, Navneet, Singh, Mini P., Prakash, Ajay, PVM, Lakshmi, Medhi, Bikash
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646370/
https://ncbi.nlm.nih.gov/pubmed/33166694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106224
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים